High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern.
dc.contributor.author | Moreira-Soto, Andres | |
dc.contributor.author | Arguedas, Mauricio | |
dc.contributor.author | Brenes, Hebleen | |
dc.contributor.author | Buján, Willem | |
dc.contributor.author | Corrales-Aguilar, Eugenia | |
dc.contributor.author | Díaz, Cecilia | |
dc.contributor.author | Echeverri, Ann | |
dc.contributor.author | Flores-Díaz, Marietta | |
dc.contributor.author | Gómez, Aarón | |
dc.contributor.author | Hernández, Andrés | |
dc.contributor.author | Herrera, María | |
dc.contributor.author | León, Guillermo | |
dc.contributor.author | Macaya, Román | |
dc.contributor.author | Kühne, Arne | |
dc.contributor.author | Molina-Mora, José Arturo | |
dc.contributor.author | Mora, Javier | |
dc.contributor.author | Sanabria, Alfredo | |
dc.contributor.author | Sánchez, Andrés | |
dc.contributor.author | Sánchez, Laura | |
dc.contributor.author | Segura, Álvaro | |
dc.contributor.author | Segura, Eduardo | |
dc.contributor.author | Solano, Daniela | |
dc.contributor.author | Soto, Claudio | |
dc.contributor.author | Stynoski, Jennifer L | |
dc.contributor.author | Vargas, Mariángela | |
dc.contributor.author | Villalta, Mauren | |
dc.contributor.author | Reusken, Chantal B E M | |
dc.contributor.author | Drosten, Christian | |
dc.contributor.author | Gutiérrez, José María | |
dc.contributor.author | Alape-Girón, Alberto | |
dc.contributor.author | Drexler, Jan Felix | |
dc.date.accessioned | 2021-10-12T20:08:39Z | |
dc.date.available | 2021-10-12T20:08:39Z | |
dc.date.issued | 2021-09-06 | |
dc.identifier.issn | 2296-858X | |
dc.identifier.pmid | 34552949 | |
dc.identifier.doi | 10.3389/fmed.2021.735853 | |
dc.identifier.uri | http://hdl.handle.net/10029/625318 | |
dc.language.iso | en | en_US |
dc.rights | Copyright © 2021 Moreira-Soto, Arguedas, Brenes, Buján, Corrales-Aguilar, Díaz, Echeverri, Flores-Díaz, Gómez, Hernández, Herrera, León, Macaya, Kühne, Molina-Mora, Mora, Sanabria, Sánchez, Sánchez, Segura, Segura, Solano, Soto, Stynoski, Vargas, Villalta, Reusken, Drosten, Gutiérrez, Alape-Girón and Drexler. | |
dc.subject | COVID-19 | en_US |
dc.subject | PRNT titers 50 | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | equine antibodies | en_US |
dc.subject | neutralization test | en_US |
dc.subject | therapy | en_US |
dc.subject | variant of concern | en_US |
dc.title | High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern. | en_US |
dc.type | Article | en_US |
dc.identifier.journal | Front Med 2021; 8:735853 | en_US |
dc.source.journaltitle | Frontiers in medicine | |
dc.source.volume | 8 | |
dc.source.beginpage | 735853 | |
dc.source.endpage | ||
dc.source.country | Switzerland |